Home
About BioSig
Overview
PURE EP™
Bioelectronic Medicine
Partnerships
Leadership
Technology
Overview
Problem
Our Solution
Publications
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
Media Resources
CEO Blog
Investors
Investor Relations
Overview
News / Events
Press Releases
IR Calendar
Email Alerts
Company Info
Profile
Presentations
Management Team
Contacts
FAQ
Financial Info
Balance Sheet
Income Statement
Cash Flow
Financial Results
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Board of Directors
Board Committees
Governance Documents
Contact
News & Media
News & Media
Overview
Press Releases
BioSig in the News
Presentations
Events
Media Resources
CEO Blog
Press Releases
All News
2019
2018
2017
2016
2015
2014
2013
2012
2011
BioSig to Present Clinical Observations at Venice Arrhythmias 2019
September 30, 2019
Global Marketing and Strategy Leader Martha Pease Joins BioSig Board of Directors
September 26, 2019
BioSig Technologies Signs a New Licensing Agreement with Mayo Clinic
September 12, 2019
BioSig‘s Subsidiary NeuroClear Technologies, Inc. Raises $3.7 million
September 5, 2019
BioSig Allowed Additional Foundational US Patent for its PURE EP(tm) System
August 1, 2019
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
July 24, 2019
Olivier Chaudoir Joins BioSig as Director of Marketing
July 18, 2019
Manasi Patwardhan Joins BioSig as Director of Strategic Planning
July 11, 2019
BioSig Technologies, Inc. Added to Membership of Russell 3000® Index
July 1, 2019
Samuel E. Navarro Appointed to BioSig Board of Directors
June 25, 2019
1
2
3
4
5
6
7
8
9
10
...16